Overview

Role of Bumetanide in Treatment of Autism

Status:
Recruiting
Trial end date:
2030-12-01
Target enrollment:
Participant gender:
Summary
Role of bumetanide in Autism
Phase:
Phase 3
Details
Lead Sponsor:
Sherief Abd-Elsalam
Treatments:
Bumetanide